Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 41.27 K285.2 K117.06 K172.51 K 616.03 K Research & development ———— — Operating income -41.27 K-285.2 K-117.06 K-172.51 K -616.03 K Non-Operating Income, Total —1.68 M1.68 M1.55 M — Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses —1.68 M1.68 M1.55 M — Unusual income/expense ———— — Pretax income -41.27 K1.4 M1.56 M1.37 M 4.29 M Equity in earnings ———— — Taxes ———— — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -41.27 K1.4 M1.56 M1.37 M 4.29 M Discontinued operations ———— — Net income -41.27 K1.4 M1.56 M1.37 M 4.29 M Dilution adjustment —1.68 M—1.55 M — Preferred dividends —1.68 M—1.55 M — Diluted net income available to common stockholders -41.27 K1.4 M1.56 M1.37 M 4.29 M Basic earnings per share (Basic EPS) -0.010.210.270.12 0.59 Diluted earnings per share (Diluted EPS) -0.010.210.270.12 0.59 Average basic shares outstanding 3.75 M15.22 M21.18 M21.56 M — Diluted shares outstanding 3.75 M9.58 M12.61 M21.56 M — EBITDA ———— — EBIT ———— — Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) ———— —